BRIEF-Boston Scientific to acquire Rhythmia Medical

Oct 8 (Reuters) - Boston Scientific Corp :

* To acquire Rhythmia Medical Inc

* Agreement calls for an upfront payment of $90 million payable upon

transaction closing

* Expects net impact of transaction on adjusted earnings per share to be

immaterial for years 2013 and 2014

* Says to offer up to an additional $175 million in contingent payments

* Says deal to be break-even to accretive after 2014

* Says once the mapping system is cleared by the U.S. Food and Drug Administration and receives CE Mark approval in Europe, Boston Scientific expects to begin a limited market launch of the system in 2013 and full market launch in 2014.

* Source text

* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))